Articles related to Multiple Myeloma
The Holiday of Lights and Heroes
With his multiple myeloma in check, David Dauman reflects on past Chanukahs with this family. Read More
Spreading Hope and Building on Faith Through A Cancer Journey
Celebrating a Life of Ministry and a Multiple Myeloma Milestone with a Very Special Patient Read More
A Unique Take on Customized Cancer Care
Husband, father and coffee aficionado Gary has become one of the first 100 patients to be treated with CAR T therapy approved for myeloma Read More
Moffitt Cancer Center Earns Blue Distinction® Specialty Care Designation for Cellular Immunotherapy – CAR-T
Hospital recognized for quality, safety and improved health outcomes in delivering therapy Read More
Refining Multiple Myeloma Treatments: the EMMA Created at Moffitt
A result of Mark Pentecost’s generous donation, the EMMA database tests a multiple myeloma patient’s sensitivity to dozens of drugs at one time to determine the best treatment. Read More
Malignant Hematology ASCO Highlights
Moffitt’s Malignant Hematology physicians and scientists were proud to share and present their research findings at American Society of Clinical Oncology (ASCO 2022) Read More
New Study Finds "Off the Shelf CAR-T" Promising for Certain Lymphoma Patients
Moffitt is one of a few hospitals nationwide testing ALLO-501a, an allogeneic CAR T therapy product from Allogene Therapeutics, in combination with ALLO-64 Read More
Comprehensive Molecular Profiling of Undifferentiated Embryonal Sarcoma of the Liver
Moffitt Cancer Center is leading the research in rare sarcomas and has performed the most comprehensive molecular analysis to-date of undifferentiated embryonal sarcoma of the liver Read More
Reshaping the Frontline Treatment Landscape of ES-SCLC
Dr. Bruna Pellini, in an interview with OncLive®, also compares the findings of the CASPIAN and IMpower133 trials and research efforts currently ongoing in ES-SCLC Read More
Improving Representation of Racial and Ethnic Minorities in Lung Cancer Screening Programs
With recent screening guidelines changes, more people are eligible for a low-dose CT scan and have the ability to participate in lung screening programs or trials. Read More
CAR T Clinical Trials for Multiple Myeloma Bring Promising New Treatments
Moffitt researchers are leaders in advancing the field of CAR T therapy and multiple myeloma clinical trials provide patients with exciting new treatment opportunities. Read More
One in a Million
As Emerald Cromwell battles a rare adrenal cancer, she learns two close friends have the same disease. Read More
Moffitt Research of Selinexor for Relapsed/Refractory Multiple Myeloma Facilitates Recent FDA Approval
Studies to expand its use in other cancers are ongoing at Moffitt Cancer Center Read More
Screening High-Risk Individuals Can Reduce Multiple Myeloma Mortality
Computational modeling approach shows screening strategies can reduce risk of precursor disease developing to multiple myeloma Read More
What is CAR T Therapy?
Dr. Frederick Locke, vice chair of the Department of Blood and Marrow Transplant and Cellular Immunotherapy, answers some frequently asked questions about CAR T cell therapy. Read More
